Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€3.71
09.01.22
-
09.01.23
-11.02%
22.01.22

Could be worthwhile Investment >10% per year
Intercept Pharmaceuticals

Start price
Target price
Perf. (%)
€13.26
09.01.22
-
09.01.23
7.05%
10.01.23

Risky Investment
buy
Magenta Therapeutics

Start price
Target price
Perf. (%)
€4.08
08.01.22
€6.00
08.01.23
-26.40%
22.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€114.10
07.01.22
€130.00
07.01.23
-63.63%
05.06.22

Could be worthwhile Investment >10% per year
buy
Valneva SE

Start price
Target price
Perf. (%)
€19.03
04.01.22
-
04.01.23
-7.46%
07.01.22

Risky Investment
buy
Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€98.65
04.01.22
-
04.01.23
-56.84%
25.08.22

Edap Tms S.A. ADR

Start price
Target price
Perf. (%)
€5.00
03.01.22
-
03.01.23
27.00%
15.05.22

Probably not worthwhile Investment
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€3.54
03.01.22
-
03.01.23
-14.69%
09.01.22

Risky Investment
buy
Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€33.72
03.01.22
-
03.01.23
-14.00%
09.01.22

Risky Investment
buy
Quantum Genomics S.A.

Start price
Target price
Perf. (%)
€4.32
31.12.21
€5.00
31.12.22
-97.78%
01.01.23

Could be worthwhile Investment >10% per year
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€134.44
30.12.21
-
30.12.22
-13.81%
09.01.22

Risky Investment
buy
Oramed Pharmaceuticals

Start price
Target price
Perf. (%)
€11.38
29.12.21
€15.00
29.12.22
-0.92%
30.12.22

Could be worthwhile Investment >10% per year
Oramed Pharmaceuticals

Start price
Target price
Perf. (%)
€10.70
29.12.21
-
29.12.22
5.37%
30.12.22

Risky Investment
Mainly gamblers invest here
Sustainability is not important
High valuation
buy
arGEN X BV

Start price
Target price
Perf. (%)
€312.20
28.12.21
-
28.12.22
11.56%
29.12.22

buy
Genocea Biosciences Inc.

Start price
Target price
Perf. (%)
€1.15
27.12.21
-
27.12.22
-18.26%
10.01.22

Could be worthwhile Investment >10% per year
buy
Pluristem Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.41
27.12.21
€2.50
27.12.22
-31.19%
28.12.22

Could be worthwhile Investment >10% per year
buy
Sorrento Therapeutics Inc.

Start price
Target price
Perf. (%)
€4.97
27.12.21
€6.00
27.12.22
-83.85%
28.12.22

Could be worthwhile Investment >10% per year
buy
Paion AG

Start price
Target price
Perf. (%)
€1.23
27.12.21
€2.00
27.12.22
-26.75%
08.09.22

Innovative
Future proof or reliable business model
Could be very worthwhile Investment >20% year
Strong uniques
buy
Radius Health Inc.

Start price
Target price
Perf. (%)
€6.35
26.12.21
-
26.12.22
-7.81%
09.01.22

Risky Investment
buy
Stratec SE

Start price
Target price
Perf. (%)
€132.00
23.12.21
-
23.12.22
-32.73%
25.08.22

buy
Mevis Medical Sol.na

Start price
Target price
Perf. (%)
€30.80
23.12.21
-
23.12.22
3.25%
25.08.22

buy
Biofrontera AG

Start price
Target price
Perf. (%)
€1.56
23.12.21
-
23.12.22
-18.27%
25.08.22

buy
Cytomx Therapeutics Inc

Start price
Target price
Perf. (%)
€3.49
21.12.21
-
21.12.22
7.56%
25.12.21

Risky Investment
buy
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€6.41
20.12.21
€7.20
20.12.22
-15.91%
30.01.22

Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
buy
CytoDyn Inc_INT

Start price
Target price
Perf. (%)
€0.88
20.12.21
€1.20
20.12.22
-25.64%
09.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies